Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
A non-randomized phase II study to determine the efficacy and safety of the combination of
Gemcitabine and Oxaliplatin followed by Gemcitabine and radiotherapy in patients with
surgically resected pancreatic cancer.